By Associate Professor Natasa Gisev

Conference Presentations

Bharat C; Gisev N; Hopkins R; Pearson SA; Gillies M; Dobbins T; Larney S; Blythe F; Degenhardt L, 2024, 'Development of opioid use disorder following treatment with opioid analgesics for non-cancer pain relief: an Australian state-wide nested case-control study', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=SwVO9ONBuE8&t=5295s

Hopkins R, 2023, '“We didn’t cause the opioid epidemic”: The experience of being prescribed opioids for chronic non-cancer pain at a time of increasing restrictions', presented at Australian Pain Society 43rd Annual Scientific Meeting, Canberra, Australia, 02 April 2023

Schaffer A; Cairns R; Brown J; Gisev N; Buckley N; Pearson S, 2020, 'Changes in sales of over‐the‐counter and prescription medicines after rescheduling of codeine to a prescription‐only medicine in Australia', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Conference Abstracts

Santo T; Gisev N; Campbell G; Colledge-Friday S; Wilson J; Tran LT; Lynch M; Martino-Burke D; Taylor S; Degenhardt L, 2024, 'Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis', in International Journal of Drug Policy, Vol. 128, http://dx.doi.org/10.1016/j.drugpo.2024.104434

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Buizen L; Degenhardt L, 2023, 'Association of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment With Mortality Among Individuals With Opioid Dependence', in DRUG AND ALCOHOL DEPENDENCE, ELSEVIER IRELAND LTD, CO, Denver, Vol. 260, presented at 85th Annual Scientific Meeting of the College-on-Problems-of-Drug-Dependence (CPDD), CO, Denver, 17 July 2023 - 21 July 2023, http://dx.doi.org/10.1016/j.drugalcdep.2023.110845

Santo T; Campbell G; Gisev N; Tran LT; Martino-Burke D; Wilson J; Colledge-Frisby S; Clark B; Degenhardt L, 2023, 'Prevalence of Comorbid Substance Use Disorders Among People With Opioid Use Disorder: A Systematic Review and Meta-Analysis', in DRUG AND ALCOHOL DEPENDENCE, ELSEVIER IRELAND LTD, CO, Denver, Vol. 260, presented at 85th Annual Scientific Meeting of the College-on-Problems-of-Drug-Dependence (CPDD), CO, Denver, 17 July 2023 - 21 July 2023, http://dx.doi.org/10.1016/j.drugalcdep.2023.110148

Santo T; Gisev N; Campbell G; Degenhardt L, 2022, 'Associations with childhood trauma and comorbid mental disorders among people with opioid dependence', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S124 - S125

Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study', in Drug and Alcohol Dependence, Vol. 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697

Peacock A; Chiu V; Leung J; Dobbins T; Larney S; Gisev N; Pearson S-A; Dunlop AJ; Degenhardt L, 2019, 'CHARACTERISING PEOPLE ATTENDING NEW SOUTH WALES EMERGENCY DEPARTMENTS AND HOSPITALS FOR AN ALCOHOL-RELATED PROBLEM, 2005-2014: THE DATA-LINKAGE ALCOHOL COHORT STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S81 - S82

Reports

Chidwick K; Bharat C; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment., UNSW Sydney, Sydney, 345, http://dx.doi.org/10.26190/ayet-f348, https://ndarc.med.unsw.edu.au/resource/real-world-dosing-intervals-long-acting-buprenorphine-opioid-agonist-treatment

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in New South Wales, 2013-2022, UNSW Sydney, Sydney, 347, http://dx.doi.org/10.26190/rzmn-a864, https://ndarc.med.unsw.edu.au/resource/nsw-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Queensland, 2013-2022, UNSW Sydney, Sydney, 349, http://dx.doi.org/10.26190/ybm1-3f83, https://ndarc.med.unsw.edu.au/resource/qld-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in South Australia, 2013-2022, UNSW Sydney, Sydney, 350, http://dx.doi.org/10.26190/y21d-yd24, https://ndarc.med.unsw.edu.au/resource/sa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Tasmania, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 351, http://dx.doi.org/10.26190/q6zj-fx75, https://ndarc.med.unsw.edu.au/resource/tas-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Australian Capital Territory, 2013-2022, UNSW Sydney; NDARC, Sydney, 346, http://dx.doi.org/10.26190/16m9-6z16, https://ndarc.med.unsw.edu.au/resource/ndarc-technical-reports-345-353

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Northern Territory, 2013-2022, UNSW Sydney, Sydney, 348, http://dx.doi.org/10.26190/mt8r-kd57, https://ndarc.med.unsw.edu.au/resource/nt-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Victoria, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 352, http://dx.doi.org/10.26190/gjpp-py45, https://ndarc.med.unsw.edu.au/resource/vic-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Western Australia, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 353, http://dx.doi.org/10.26190/ftbz-w461, https://ndarc.med.unsw.edu.au/resource/wa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chrzanowska A; Gisev N; Price O; Sutherland R; Memedovic S; Degenhardt L; Farrell M; Peacock A, 2020, Tapentadol use and harms in Australia: Analysis of opioid sales data and sentinel survey data from people who inject drugs, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5ef15b883c0ac

Gisev N; Larney S; Kimber J; Burns L; Weatherburn D; Gibson A; Dobbins T; Mattick R; Butler T; Degenhardt L, 2014, Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22 year data linkage study, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 330, https://ndarc.med.unsw.edu.au/resource/determining-impact-opioid-substitution-therapy-upon-mortality-and-recidivism-among

Nielsen S; Degenhardt L; Hoban B; Gisev N, 2014, Comparing opioids: A guide to estimating oral morphine equivalents (OME) in research, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 329, https://ndarc.med.unsw.edu.au/resource/comparing-opioids-guide-estimating-oral-morphine-equivalents-ome-research

Theses / Dissertations

Gisev N, 2014, An Evaluation of Psychotropic Medicines Use: Patterns and Outcomes

Preprints

Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson S-A, 2024, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia, http://dx.doi.org/10.1101/2024.04.29.24306520

Costa JDO; Bruno C; Baranwal N; Gisev N; Dobbins T; Degenhardt L; Pearson SA, 2020, Variations in Long-Term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000–2019), http://dx.doi.org/10.22541/au.160192979.95446629/v1

Back to profile page